Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2017

View Archived Issues

Nature Cell starts U.S. trials for Astrostem stem cell therapy for Alzheimer's disease

MDA grant supports Izumi's early stage development of IZ-10023 for ALS

Mouse model developed for the study of alpha-gal meat allergy

IL13RA1 as a new prognostic marker for invasive breast cancer

Major vault protein as a new marker to distinguish leiomyoma from leiomyosarcoma

Sunovion seeks FDA approval for Aptiom for pediatric partial-onset seizures

Kissei and Maruishi to collaborate on development and marketing of MR-13A9 in Japan

ViiV Healthcare UK presents novel HIV integrase inhibitors

Celgene designates development candidate from MTAP pathway program under Agios agreement

Pfizer patents IRAK-4 inhibitors

Phase Ib data warrant progression of Heat Biologics' trial of HS-110 with nivolumab in NSCLC

Sichuan Kelun Pharmaceutical Research Institute discovers dipeptidyl peptidase 4 inhibitors

Marker can indicate desensitization during immunotherapy for milk allergy

SBI enters into Japanese marketing agreement with Chugai for Alaglio

Portola Pharmaceuticals presents novel PCSK9 inhibitors

Pfizer launches Zavicefta in U.K. and Germany

FDA approves Kisqali for HR+/HER2- breast cancer

Phase III results confirm long-term safety of Indivior's RBP-7000 in schizophrenia

Charles River Laboratories and Chiesi extend respiratory drug discovery partnership

Phase III study of Repatha in patients with high LDL-C on apheresis meets endpoints

Stellar Biotechnologies and Matrivax sign technology transfer agreement for C. difficile technology

Myriad Genetics launches EndoPredict test in U.S. for breast cancer

Grants support reMYND's work in epilepsy and Alzheimer's disease

Toray Industries and Maruho sign worldwide agreement for RORgammat inhibitor

OncBioMune completes acquisition of Vitel Laboratorios

CRISPR Therapeutics and Casebia sign commercial license agreement with MaxCyte

Transcriptional coactivator YAP1 found to be expressed in high-grade endometrial carcinomas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...